Saturn V Capital Management as of June 30, 2024
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 26 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 10.4 | $28M | 64k | 430.04 | |
| Disc Medicine (IRON) | 8.6 | $23M | 503k | 45.07 | |
| Crinetics Pharmaceuticals In (CRNX) | 8.1 | $22M | 480k | 44.79 | |
| Vaxcyte (PCVX) | 6.2 | $16M | 216k | 75.51 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 5.8 | $15M | 113k | 136.38 | |
| Cytokinetics Com New (CYTK) | 5.6 | $15M | 272k | 54.18 | |
| BioMarin Pharmaceutical (BMRN) | 5.6 | $15M | 179k | 82.33 | |
| Cogent Biosciences (COGT) | 5.3 | $14M | 1.7M | 8.43 | |
| Cargo Therapeutics (CRGX) | 5.3 | $14M | 857k | 16.42 | |
| Kalvista Pharmaceuticals (KALV) | 5.0 | $13M | 1.1M | 11.78 | |
| Celcuity (CELC) | 4.7 | $13M | 761k | 16.38 | |
| Merus N V (MRUS) | 3.7 | $9.7M | 165k | 59.17 | |
| Syndax Pharmaceuticals (SNDX) | 3.3 | $8.6M | 420k | 20.53 | |
| Abivax Sa Sponsored Ads (ABVX) | 3.1 | $8.3M | 628k | 13.22 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 2.7 | $7.3M | 1.1M | 6.52 | |
| Amicus Therapeutics (FOLD) | 2.7 | $7.1M | 714k | 9.92 | |
| Anaptysbio Inc Common (ANAB) | 2.4 | $6.3M | 250k | 25.06 | |
| Phathom Pharmaceuticals (PHAT) | 2.3 | $6.1M | 593k | 10.30 | |
| Iteos Therapeutics | 2.1 | $5.5M | 367k | 14.84 | |
| Inozyme Pharma (INZY) | 1.9 | $5.1M | 1.1M | 4.46 | |
| Neumora Therapeutics (NMRA) | 1.4 | $3.8M | 390k | 9.83 | |
| Enliven Therapeutics (ELVN) | 1.3 | $3.6M | 152k | 23.37 | |
| Longboard Pharmaceuticals In | 0.7 | $1.9M | 71k | 27.03 | |
| Rapport Therapeutics (RAPP) | 0.6 | $1.6M | 70k | 23.26 | |
| Morphic Hldg (MORF) | 0.6 | $1.6M | 48k | 34.07 | |
| Contineum Therapeutics Cl A (CTNM) | 0.5 | $1.3M | 73k | 17.61 |
